Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second Look Laparoscopy With HIPEC in Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
NCT04415944Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2021
- Primary completion
- Sep 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in ovarian epithelial cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by Wake Forest University Health Sciences. Started May 2021; status: completed.
02
Drugs
carboplatin
03
Conditions
ovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT04415944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415944.